Stroke continues to be an extremely prevalent disease and poses a great challenge in developing safe and effective therapeutic options. Hyperbaric oxygen therapy (HBOT) has demonstrated significant pre-clinical effectiveness for the treatment of acute ischemic stroke, and limited potential in treating chronic neurological deficits. Reported benefits include reductions in oxidative stress, inflammation, neural apoptosis, and improved physiological metrics such as edema and oxygen perfusion, all of which contribute to improved functional recovery.
Hyperbaric oxygen treatment of fibromyalgia: a prospective observational clinical study.
Abstract: Fibromyalgia (FM) is a syndrome of unknown aetiology that is characterised by widespread musculoskeletal pain, fatigue and disordered sleep, and often associated with neuropsychiatric and cognitive symptoms. Current treatment options are only partially...
Hyperbaric oxygen therapy: Antimicrobial mechanisms and clinical application for infections.
Abstract: Hyperbaric oxygen therapy (HBOT) is a treatment procedure that involves breathing 100% O for a certain time and under a certain pressure. HBOT is commonly administrated as a primary or alternative therapy for different diseases such as infections. In this...
Drowning in fresh or salt water: respective influence on respiratory function in a matched cohort study.
Abstract: For the most severe drowned patients, hypoxemia represents one of the major symptoms. As the influence of the type of water (fresh or salt water) on respiratory function is still unclear, the primary endpoint of this multicenter study was to compare...
Hyperbaric oxygen and aerobic exercise in the long-term treatment of fibromyalgia: A narrative review.
Abstract: Chronic pain is one of the most common clinical presentations in the primary care settings. In the US, Fibromyalgia (FM) affects about 1-3% of adults and commonly occurs in adults between the ages of 40-50 years. FM causes widespread muscular pain and...
Hyperbaric Oxygen Alleviates the Inflammatory Response Induced by LPS Through Inhibition of NF-κB/MAPKs-CCL2/CXCL1 Signaling Pathway in Cultured Astrocytes.
Abstract: The purpose of this study was to investigate the inhibition neuroinflammation mechanisms of hyperbaric oxygen therapy (HBOT). Primary astrocytes were incubated with lipopolysaccharide (LPS) after which they underwent HBOT and separate administration of...
Clinical predictors of the effectiveness of tiotropium in adults with symptomatic asthma: a real-life study.
Abstract: Long-acting muscarinic antagonist (LAMA) tiotropium improved lung function and reduced risks of exacerbation when added on to inhaled corticosteroids (ICS) with or without long-acting B agonists (LABAs) in patients with uncontrolled asthma. However, studies...
[Hyperbaric Oxygen Therapy and Acute Carbon Monoxide Poisoning].
Abstract: Carbon monoxide poisoning is the most commonly seen cause of poisoning in the emergency room (ER). The high affinity between carbon monoxide and hemoglobin and their complex biological characteristics greatly increase the risks of cardiac, nervous, muscular,...
Clinical Trial – ED50 and ED95 of Intrathecal Hyperbaric Bupivacaine With Fentanyl for Transurethral Prostatectomy in Elderly Patients
As people age, the incidence of prostate hyperplasia increases. So patients under
Transurethral Resection of Prostate(TURP) or Holmium Laser Ennucleation of Prostate(HoLEP)
are mostly ole age people. Most old age patient has several underlying disease. So patients
can develop high mortality and morbidity. Most surgeries for Prostate Resection are taken
under Spinal anesthesia. Adequate block level for Prostate Resection is T10. But sometimes,
old age patients can develop severe complication after spinal anesthesia. So we started this
study to know the adequate drug concentration for Spinal anesthesia taken for Prostate
Resection surgery.
Effect of hyperbaric oxygen therapy on HMGB1/NF-κB expression and prognosis of acute spinal cord injury: A randomized clinical trial.
Although there are reports of the beneficial effects of hyperbaric oxygen (HBO) therapy in experimental settings, there are few clinical trials of HBO therapy for acute spinal cord injury (SCI). We investigated the effect of HBO in acute SCI by measuring plasma high mobility group box 1 (HMGB1) and nuclear factor kappa-B (NF-κB) levels, and by monitoring changes in electromyogram F-persistence (the percentage of discernible F-waves) and F-chronodispersion (the difference between minimal and maximal latency). We enrolled 79 acute SCI patients and randomly divided them into control (conventional treatment) and the treatment (conventional treatment plus HBO therapy) groups. Plasma was collected before treatment and after treatment on 1st, 3rd, 7th, 10th and 30th day for the measurement of HMGB1 and NF-κB. Electromyogram F-waves were detected before therapy and after therapy on the 10th and 30th days.